These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Long-term dietary quercetin enrichment as a cardioprotective countermeasure in mdx mice. Ballmann C; Denney T; Beyers RJ; Quindry T; Romero M; Selsby JT; Quindry JC Exp Physiol; 2017 Jun; 102(6):635-649. PubMed ID: 28192862 [TBL] [Abstract][Full Text] [Related]
26. Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse. Reay DP; Niizawa GA; Watchko JF; Daood M; Reay JC; Raggi E; Clemens PR Mol Med; 2012 May; 18(1):466-76. PubMed ID: 22231732 [TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869 [TBL] [Abstract][Full Text] [Related]
28. Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy. Kim JH; Kwak HB; Thompson LV; Lawler JM J Muscle Res Cell Motil; 2013 Feb; 34(1):1-13. PubMed ID: 23104273 [TBL] [Abstract][Full Text] [Related]
29. Urine titin as a novel biomarker for Duchenne muscular dystrophy. Ishii MN; Nakashima M; Kamiguchi H; Zach N; Kuboki R; Baba R; Hirakawa T; Suzuki K; Quinton M Neuromuscul Disord; 2023 Apr; 33(4):302-308. PubMed ID: 36871413 [TBL] [Abstract][Full Text] [Related]
30. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Messina S; Altavilla D; Aguennouz M; Seminara P; Minutoli L; Monici MC; Bitto A; Mazzeo A; Marini H; Squadrito F; Vita G Am J Pathol; 2006 Mar; 168(3):918-26. PubMed ID: 16507907 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016 [TBL] [Abstract][Full Text] [Related]
32. Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin. Albuquerque-Pontes GM; Casalechi HL; Tomazoni SS; Serra AJ; Ferreira CSB; Brito RBO; de Melo BL; Vanin AA; Monteiro KKDS; Dellê H; Frigo L; Marcos RL; de Carvalho PTC; Leal-Junior ECP Lasers Med Sci; 2018 May; 33(4):755-764. PubMed ID: 29209866 [TBL] [Abstract][Full Text] [Related]
33. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755 [TBL] [Abstract][Full Text] [Related]
34. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy. Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351 [TBL] [Abstract][Full Text] [Related]
35. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles? Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920 [TBL] [Abstract][Full Text] [Related]
36. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Rayavarapu S; Coley W; Cakir E; Jahnke V; Takeda S; Aoki Y; Grodish-Dressman H; Jaiswal JK; Hoffman EP; Brown KJ; Hathout Y; Nagaraju K Mol Cell Proteomics; 2013 May; 12(5):1061-73. PubMed ID: 23297347 [TBL] [Abstract][Full Text] [Related]
37. Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model. Siemionow M; Brodowska S; Langa P; Zalants K; Kozlowska K; Grau-Kazmierczak W; Heydemann A Arch Immunol Ther Exp (Warsz); 2022 Aug; 70(1):20. PubMed ID: 35978142 [TBL] [Abstract][Full Text] [Related]
38. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation. Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487 [TBL] [Abstract][Full Text] [Related]
39. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy. Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755 [TBL] [Abstract][Full Text] [Related]